NeoGenomics, Inc.

NEO ·Healthcare, Diagnostics & Research, United States
Balance Sheet Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2023

Total Assets: $1.68B

Liabilities Breakdown FY2023

Total Liabilities: $739.7M